BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32085659)

  • 21. GFI1 Cooperates with IKZF1/IKAROS to Activate Gene Expression in T-cell Acute Lymphoblastic Leukemia.
    Sun W; Guo J; McClellan D; Poeschla A; Bareyan D; Casey MJ; Cairns BR; Tantin D; Engel ME
    Mol Cancer Res; 2022 Apr; 20(4):501-514. PubMed ID: 34980595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular signaling and epigenetic regulation of gene expression in leukemia.
    Gowda C; Song C; Ding Y; Iyer S; Dhanyamraju PK; McGrath M; Bamme Y; Soliman M; Kane S; Payne JL; Dovat S
    Adv Biol Regul; 2020 Jan; 75():100665. PubMed ID: 31623972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
    Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
    Vairy S; Tran TH
    Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative splicing of Ikaros regulates the FUT4/Le
    Yi L; Hu Q; Zhou J; Liu Z; Li H
    Biochem Biophys Res Commun; 2019 Feb; 510(1):128-134. PubMed ID: 30683310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
    Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
    Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
    Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
    J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
    Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
    Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ikaros, CK2 kinase, and the road to leukemia.
    Dovat S; Song C; Payne KJ; Li Z
    Mol Cell Biochem; 2011 Oct; 356(1-2):201-7. PubMed ID: 21750978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
    Ge Z; Song C; Ding Y; Tan BH; Desai D; Sharma A; Gowda R; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Iyer S; Dhanyamraju PK; Imamura Y; Bogush D; Bamme Y; Yang Y; Soliman M; Kane S; Dovat E; Schramm J; Hu T; McGrath M; Chroneos ZC; Payne KJ; Gowda C; Dovat S
    Leukemia; 2021 May; 35(5):1267-1278. PubMed ID: 33531656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
    Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
    Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sumoylation Inhibits the Growth Suppressive Properties of Ikaros.
    Apostolov A; Litim-Mecheri I; Oravecz A; Goepp M; Kirstetter P; Marchal P; Ittel A; Mauvieux L; Chan S; Kastner P
    PLoS One; 2016; 11(6):e0157767. PubMed ID: 27315244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
    Ge Z; Gu Y; Han Q; Sloane J; Ge Q; Gao G; Ma J; Song H; Hu J; Chen B; Dovat S; Song C
    Epigenomics; 2018 Jan; 10(1):59-69. PubMed ID: 28994305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia.
    Iacobucci I; Iraci N; Messina M; Lonetti A; Chiaretti S; Valli E; Ferrari A; Papayannidis C; Paoloni F; Vitale A; Storlazzi CT; Ottaviani E; Guadagnuolo V; Durante S; Vignetti M; Soverini S; Pane F; Foà R; Baccarani M; Müschen M; Perini G; Martinelli G
    PLoS One; 2012; 7(7):e40934. PubMed ID: 22848414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.
    Ma H; Qazi S; Ozer Z; Zhang J; Ishkhanian R; Uckun FM
    PLoS One; 2013; 8(8):e71302. PubMed ID: 23977012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of aberrantly spliced oncogenic Ikaros isoforms coupled with clonal IKZF1 deletions and chimeric oncogenes in acute lymphoblastic leukemia.
    Vshyukova V; Valochnik A; Meleshko A
    Blood Cells Mol Dis; 2018 Jul; 71():29-38. PubMed ID: 29496375
    [No Abstract]   [Full Text] [Related]  

  • 40. Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia.
    Virely C; Moulin S; Cobaleda C; Lasgi C; Alberdi A; Soulier J; Sigaux F; Chan S; Kastner P; Ghysdael J
    Leukemia; 2010 Jun; 24(6):1200-4. PubMed ID: 20393504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.